NL-OMON24645招募中不适用
SARS-CoV-2 immune response in asymptomatic patients
Amsterdam UMC, location AMC0 个研究点目标入组 75 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult (age = 18 years)
- •-Screened for COVID-19 according to the national guidelines because of a planned surgical or interventional procedure under general anesthesia.
- •-Tested positive for SARS-CoV-2 with RT-PCR.
- •-Asymptomatic at the moment of screening: no suspicion for COVID-19 for at least 48 hours prior to screening, based on a standardized questionnaire containing the following complaints: cough, dyspnoea, fever, general malaise, myalgia, headache, extreme fatigue (new onset), throat ache, obstructed/runny nose, loss of smell, loss of taste, abdominal pain, diarrhoea and vomiting.
排除标准
- •-Not able or willing to give informed consent.
研究者
相似试验
已完成
不适用
SARS-CoV-2 immune response in asymptomatic patientsCOVID-19SARS-CoV-210047438NL-OMON50161Academisch Medisch Centrum75
已完成
不适用
SARS-CoV-2 serology by mild symptoms of diseaseSARS-CoV-2 infection10047438NL-OMON50020Medlon b.v. Medische Diagnostiek39
进行中（未招募）
1 期
Response to corona vaccination in patients with primary Sjögren's syndromePrimary Sjögren's syndromeEUCTR2021-001414-10-NLniversity Medical Center Groningen180
已完成
4 期
Vaccine response against SARS-CoV-2 in patients with primary Sjögren*s syndrome1000381610047438Sjögren's syndromeNL-OMON51179niversitair Medisch Centrum Groningen180
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400